Abstract
E1-deleted adenoviral vectors expressing the bacterial β-galactosidase gene were inoculated into the brain of unprimed and primed C3H.He or C57BL/6J mice housed under either conventional or specific-pathogen-free (SPF) conditions. The kinetics of immune responses to both the vector and the transgene were investigated. In mice previously sensitized to adenovirus, the leukocyte infiltrate in the brain was dominated by CD8+ T cells, whereas in unprimed mice CD4+ T cells were present at higher levels. As expected, antibody titres to both adenovirus and β-galactosidase were higher in primed mice than in unprimed mice after intracranial inoculation. C3H.He mice consist- ently made higher antibody responses than C57BL/6J mice. Although adenoviral vectors induced an inflammatory response under all conditions, mice housed in SPF facilities exhibited less inflammation than conventional mice and transgene expression persisted for longer. Irrespective of whether the mice had been deliberately primed to adenovirus, antibody titres were consistently lower in SPF mice compared with conventional mice. This study clearly demonstrates that environmental conditions, as well as previous priming to adenovirus, will affect both the quality and duration of the immune response triggered by gene delivery to the brain.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Simon RH et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study Hum Gene Ther 1993 4: 771–780
Yang Y, Li Q, Ertl HCJ, Wilson JM . Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses J Virol 1995 69: 2004–2015
Yang Y et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses gene transfer Proc Natl Acad Sci USA 1994 91: 4407–4411
Yang Y, Ertl HCJ, Wilson JM . MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E-1 deleted recombinant adenoviruses Immunity 1994 1: 433–442
Dai Y et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression Proc Natl Acad Sci USA 1995 92: 1401–1405
Byrnes AP et al. Adenovirus gene transfer causes inflammation in the brain Neuroscience 1995 66: 1015–1024
Byrnes AP, Wood MJA, Charlton HM . Role of T cells in the inflammation caused by adenovirus vectors in the brain Gene Therapy 1996 3: 644–651
Wood MJA et al. Immune responses to adenovirus vectors in the nervous system Trends Neurosci 1996 19: 497–501
Kajiwara K et al. Immune responses to adenoviral vectors during gene transfer in the brain Hum Gene Ther 1997 8: 253–265
Korber B, Mermod N, Hood L, Stroynowski I . Regulation of gene expression by interferons: control of H-2 promoter responses Science 1988 239: 1302–1306
Gribaudo G et al. Interferons inhibit onset of murine cytomegalovirus immediate–early gene transcription Virology 1993 197: 303–311
Harms JS, Splitter GA . Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter Hum Gene Ther 1995 6: 1291–1297
Qin L et al. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression Hum Gene Ther 1997 8: 2019–2029
Mack CA et al. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype Hum Gene Ther 1997 8: 99–109
Knight V, Kasel JA . Viral and mycoplasmal infections of the respiratory tract. In: Knight V (ed) . Adenoviruses Lea and Febiger: Philadelphia 1973 65
Williams KA, Hart DNJ, Fabre JW, Morris PJ . Distribution and quantitation of HLA-ABC and DR (Ia) antigens on human kidney and other tissues Transplantation 1980 29: 274–279
Hart DNJ, Fabre JW . Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissue, but not brain J Exp Med 1981 154: 347–361
Matyszak MK, Perry VH . The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system Neuroscience 1996 74: 599–608
Bell MD et al. Recombinant human adenovirus with rat MIP-2 gene insertion causes prolonged PMN recruitment to the murine brain Eur J Neurosci 1996 8: 1803–1811
Steinman RM . The dendritic cell system and its role in immunogenicity Annu Rev Immunol 1991 9: 271–296
Akli S et al. Transfer of a foreign gene into the brain using adenovirus vectors Nat Genet 1993 3: 224–228
Davidson BL et al. A model system for in vivo gene transfer into the CNS using an adenoviral vector Nat Genet 1993 3: 219–223
Geddes BJ, Harding TC, Lightman SL, Uney JB . Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin Nature Med 1997 3: 1402–1404
Horellou P, Sabaté O, Buc-Caron M-H, Mallet J . Adenovirus-mediated gene transfer to the central nervous system for Parkinson’s disease Exp Neurol 1997 144: 131–138
Byrnes AP, Maclaren RE, Charlton HM . Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression and demyelination J Neurosci 1996 16: 3045–3055.
Stratford-Perricaudet LD et al. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector Hum Gene Ther 1990 1: 241–256
Rosenfeld MA et al. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo Science 1991 252: 431–434
Yang Y et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis Nat Genet 1994 7: 362–369
Karougliak V, Graham FL . Development of cell lines capable of complementing E1, E4 and protein IX defective adenovirus type 5 mutants Hum Gene Ther 1995 6: 1575–1586
Wang Q, Finer MH . Second-generation adenovirus vectors Nature Med 1996 2: 714–716
Wang Q et al. Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vector Gene Therapy 1997 4: 393–400
Schowalter DB et al. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression Gene Therapy 1997 4: 853–860
Qin L et al. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen Hum Gene Ther 1997 8: 1365–1374
Jooss K, Yang Y, Wilson JM . Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung Hum Gene Ther 1996 7: 1555–1566
Cichon G, Strauss M . Transient immunosuppression with 15-deoxyspergualin prolongs reporter gene expression and reduces humoral immune response after adenoviral gene transfer Gene Therapy 1998 5: 85–90
Bushell A, Morris PJ, Wood KJ . Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response Eur J Immunol 1995 25: 2643–2649
Guérette B et al. Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig Hum Gene Ther 1996 7: 1455–1463
Jooss K, Turka LA, Wilson JM . Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig Gene Therapy 1998 5: 309–319
Kägi D et al. Cytotoxic mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice Nature 1994 369: 31–37
Cardin RD, Brooks JW, Sarawar SR, Doherty PC . Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cell J Exp Med 1996 184: 863–871
Nash AA, Sunil-Chandra NP . Interactions of murine gammaherpesvirus with the immune system Curr Opin Immunol 1994 6: 560–563
Bender BS, Croghan T, Zhang L, Small PA Jr . Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge J Exp Med 1992 175: 1143–1145
Graham MB, Braciale VL, Braciale TJ . Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection J Exp Med 1994 180: 1273–1282
Tripp RA, Safawar SR, Doherty PC . Characteristics of the influenza virus specific CD8+ T cell response in mice homozygous for disruption of the H-2 IAb gene J Immunol 1995 155: 2955–2959
Stevenson PG, Hawke S, Sloan DJ, Brangham RM . The immunogenicity of intracerebral virus infection depends on anatomical site J Virol 1997 71: 145–151
Yang Y, Wilson JM . Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo J Immunol 1995 155: 2564–2570
Müllbacher A, Blanden RV . Murine cytotoxic T-cell response to alphavirus is associated mainly with H-2Dk Immunogenetics 1978 7: 551–561
Ashman RB . Persistence of cell-mediated immunity to influenza A virus in mice Immunology 1982 47: 165–168
Jamieson BD, Ahmed R . T cell memory. Long-term persistence of virus-specific cytotoxic T cells J Exp Med 1989 169: 1993–2005
Madsen JC, Wood KJ, Morris PJ . Effects of anti-L3T4 and anti-LYT2 monoclonal antibody therapy on cardiac allograft survival in presensitized recipients Transplant Proc 1989 21: 1022
Razvi ES, Welsh RM, Mcfarland HI . In vivo state of antiviral CTL precursors J Immunol 1995 154: 620–632
Yang H, Welsh RM . Induction of alloreactive cytotoxic T cells by acute virus infection of mice J Immunol 1986 136: 1186–1193
Yang H, Dundon PL, Nahill SR, Welsh RM . Virus-indiced polyclonal cytotoxic T lymphocytes stimulation J Immunol 1989 142: 1710–1718
Tough DF, Sprent J . Virus and T cell turnover: evidence for bystander proliferation Immunol Rev 1996 150: 129–142
Lule J et al. The spontaneous development of immune complex type glomerular lesions in outbred mice is dependent on environmental factors and sex J Clin Lab Immunol 1989 29: 111–118
Allansmith MR et al. The immune response of the lacrimal grand to antigenic exposure Curr Eye Res 1987 6: 921–927
Gallimore A et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes J Exp Med 1998 187: 1383–1393
McMichael AJ . T cell responses and viral escape Cell 1998 93: 673–676
Barr D et al. Strain-related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains Gene Therapy 1995 2: 151–155
Demant P, Lipoldova M, Svobodova M . Resistance to Leishmania major in mice Science 1996 274: 1392–1393
Gorham JD et al. Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses Proc Natl Acad Sci USA 1996 93: 12467–12472
Rawle FC et al. Specificity of the mouse cytotoxic T lymphocyte response to adenovirus type 5 J Immunol 1991 146: 3977–3984
Kaplan JM et al. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung Hum Gene Ther 1997 8: 45–56
Alpers JH, Steward MW, Soothill JF . Differences in immune elimination in inbred mice Clin Exp Immunol 1972 12: 121–132
Smith TAG et al. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice Nat Genet 1993 5: 397–402
Juillard V et al. Long-term humoral and cellular immunity induced by a signal immunization with replication-defective adenovirus recombinant vector Eur J Immunol 1995 25: 3467–3473
Michou AI et al. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression Gene Therapy 1997 4: 473–482
Springer T, Galfé G, Secher DS, Milstein C . Monoclonal xenogenic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens Eur J Immunol 1978 8: 539–551
Tomonari K . A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex Immunogenetics 1988 28: 455–458
Qin S et al. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction Eur J Immunol 1987 17: 1159–1165
Cobbold SP et al. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo Nature 1984 312: 548–551
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohmoto, Y., Wood, M., Charlton, H. et al. Variation in the immune response to adenoviral vectors in the brain: influence of mouse strain, environmental conditions and priming. Gene Ther 6, 471–481 (1999). https://doi.org/10.1038/sj.gt.3300851
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300851
Keywords
This article is cited by
-
Microglial priming in neurodegenerative disease
Nature Reviews Neurology (2014)
-
Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration
Seminars in Immunopathology (2013)
-
Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia
Journal of Neuroinflammation (2012)
-
Electrophysiological characterization of NSCs after differentiation induced by OEC conditioned medium
Acta Neurochirurgica (2011)
-
Adenoviral transfer of a single donor-specific MHC class I gene to recipient bone marrow cells can induce specific immunological unresponsiveness in vivo
Gene Therapy (2002)